Meridian Venture Partners II GP, L.P. → ANI PHARMACEUTICALS INC ANIP

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 20/100 · Filer 90d Win Rate: 50% · Hist. 90d Edge: -4.5%

Passive Schedule 13G filer baseline
Held by 1 tracked 13F institutional manager
Elevated short days-to-cover (10.1 DTC)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

4 transactions

0 buys · 3 sales · 1 awards/exercises

Issuer Cluster

4 13D/G filings on this issuer

3 other filings besides this one

Filer Track Record

4 filings by this filer

3 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 10.10

3,472,078 shares short · -0.6% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $9.57M

Point72 Asset Mgmt

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-09-14	Cook Meredith	officer	Sale	500	$70.79	$35K
2026-09-11	Thoma Jeanne	director	Sale	1,000	$71.53	$72K
2026-07-02	CAREY STEPHEN P.	officer	Option exercise	3,313	$49.51	$164K
2026-07-02	CAREY STEPHEN P.	officer	Sale	3,313	$86.00	$285K

Other 13D/G Filings on ANI PHARMACEUTICALS INC

Filed	Form	Filer	Stake	Shares
2025-08-22	SCHEDULE	Meridian Venture Partners II GP, L.P.	4.80%	1,034,570	view →
2025-03-13	SCHEDULE	Meridian Venture Partners II GP, L.P.	5.40%	1,184,570	view →
2023-12-18	SC	Meridian Venture Partners II GP, L.P.	—	—	view →

Other Filings by Meridian Venture Partners II GP, L.P.

Filed	Form	Issuer	Stake	Shares
2025-08-22	SCHEDULE	ANI PHARMACEUTICALS INC ANIP	4.80%	1,034,570	view →
2025-03-13	SCHEDULE	ANI PHARMACEUTICALS INC ANIP	5.40%	1,184,570	view →
2023-12-18	SC	ANI PHARMACEUTICALS INC ANIP	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →